Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz to Nevirapine Switch in HIV-1 Infected Patients With Severe Dyslipidemia
NCT00405171Phase 4Completed
- Sponsor
- CHU Caen Normandie
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nevirapine in human immunodeficiency virus infection (HIV), hypercholesterolemia, sponsored by CHU Caen Normandie. Started Jun 2003; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)hypercholesterolemia
Beyond the preview
Go deeper on NCT00405171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405171.